Navigation Links
US HIFU Adds Mark Carol, MD, As Chief Development Officer
Date:5/14/2012

Maryland.

"I am excited about the future of this technology as we work to optimize the platform," said Dr. Carol. "Our ongoing development will focus on improving efficacy even further and minimizing the duration of the procedure. In addition, we look forward to enhancing the interface to allow a more straight-forward user experience."

In other news, US HIFU recently reported that the company's Sonablate System was used in a key study at the University College of London to deliver focal treatment for prostate cancer. The outcome of this initial study indicates HIFU may provide an alternative to traditional treatment with significantly fewer side effects, according to results published in the current issue of Lancet Oncology (DOI:10.1016/S1470- 2045(12)70121-3).

In addition, although still investigational in the United States, recent HIFU treatment guidelines have been issued by the National Institute for Health and Clinical Excellence (NICE), the independent organization responsible for providing national guidance and standards on the promotion of good health and the prevention and treatment of ill health in the United Kingdom. NICE interventional procedure guidance 424, "Focal therapy using high-intensity focused ultrasound for localised prostate cancer," indicates current evidence on focal therapy using HIFU for localized prostate cancer raises no major safety concerns. The NICE guidelines also state that patients treated with targeted high-intensity ultrasound could avoid many of the risks of more extensive procedures that treat the whole prostate gland. For more information, visit http://guidance.nice.org.uk/ipg424 

"We are very encouraged by the results of the Lancet Oncology published study and the guidelines which demonstrate how HIFU can be used to further refine the boundaries of the emerging field of focal therapy," said Dr. Carol. "These events provide suppo
'/>"/>

SOURCE USHIFU, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Nader Naeymi-Rad Appointed Chief Operating Officer at Campbell Alliance
2. Arno Therapeutics Announces Appointment of Brian Lenz, CPA as Chief Financial Officer
3. RHEI Pharmaceuticals Appoints Dr. Geert Cauwenbergh as Chief Executive Officer
4. ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer
5. Micromet, Inc. Appoints Barclay Phillips as Senior Vice President and Chief Financial Officer
6. Anesiva Announces Appointment of William Houghton, M.D. as Senior Vice President and Chief Medical Officer
7. Algenol Biofuels Appoints Chief Science Officer
8. Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors
9. Chief Technology Officer Joins ACAMP
10. Sound Surgical Technologies Welcomes Dr. Mark Schafer as New Chief Technology Officer and Vice President of Research & Development
11. LS9, Inc. Appoints Bill Haywood Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  Array BioPharma Inc. (NASDAQ: ... reached a definitive agreement with Novartis Pharma AG to ... currently in Phase 3 development.  This agreement is conditional on ... PLC (GSK) on April 22, 2014, which are expected to ...
(Date:1/22/2015)... Bedford, NH (PRWEB) January 22, 2015 ... offers a table top laboratory homogenizer, the PandaPLUS 2000, ... nanoparticles, nanodispersions, nanoemulsions , and cell disruption . ... processing dairy products, fruit juices, liquid food, food additives ...
(Date:1/22/2015)... 22, 2015 Crystal Diagnostics (CDx) Xpress System, ... has received AOAC-PTM Certifications for the six non-O157 Shiga toxin-producing ... collectively referred to as STEC or the “Big-6”) as well ... unit (cfu) per 325 g of raw ground beef and ...
(Date:1/22/2015)... Switzerland (PRWEB) January 22, 2015 Selexis ... characterized mammalian Research Cell Banks (RCBs) used for drug ... Research Cell Banks will include Next-Generation Sequencing ... genetic architecture de-risks biologic manufacturing by ensuring the integrity ...
Breaking Biology Technology:Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 2Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 3Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 4Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 5Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 6Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 7GEA Niro Soavi Announces the PandaPLUS 2000 Homogenizer for Processing New Applications for Nanoemulsions and Cell Disruption 2Crystal Diagnostics Awarded AOAC-PTM Accreditation for the Rapid Detection of “Big 6” E.coli Food Pathogens 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2
... National Ergonomics Conference and Exposition (NECE) at Caesars Palace, Las ... annual gathering of ergonomics decision makers and ergonomics product sellers ... all of the 50 states, Canada, and a dozen foreign ... , Attendees from Apple, Bayer, Chevron, ...
... the American Society of Hematology Annual Meeting , ... Corporation (Nasdaq: ACEL ) today announced that American ... (2008 112: Abstract 4205 & 2008 112: Abstract 4010) ... in chronic lymphocytic leukemia (CLL) and acute myeloblastic leukemia (AML) ...
... Growth Of 23% , , ... Microbix announced results for the fiscal year ended September 30, ... fund Microbix Biosystems Inc.,s (TSX:MBX) late-stage pipeline opportunities which are ... term, according to William J. Gastle, CEO of the Company. ...
Cached Biology Technology:National Ergonomics Expo Sees 86% On-Site Exhibitor Renewal Rate for 2009; New Products from Contour Design, Equipois, Goldtouch and Herman Miller Win 2008 NECE Attendees' Choice New Product Awards 2Alfacell's ONCONASE(R) and R-Amphinase Show Anti-Tumor Activity in Chronic Lymphocytic Leukemia and Acute Myeloblastic Leukemia Cells 2Alfacell's ONCONASE(R) and R-Amphinase Show Anti-Tumor Activity in Chronic Lymphocytic Leukemia and Acute Myeloblastic Leukemia Cells 3Alfacell's ONCONASE(R) and R-Amphinase Show Anti-Tumor Activity in Chronic Lymphocytic Leukemia and Acute Myeloblastic Leukemia Cells 4Alfacell's ONCONASE(R) and R-Amphinase Show Anti-Tumor Activity in Chronic Lymphocytic Leukemia and Acute Myeloblastic Leukemia Cells 5Microbix Uses Core Business Cashflow To Fund Late-Stage Pipeline To Build Shareholder Value In 2009 2Microbix Uses Core Business Cashflow To Fund Late-Stage Pipeline To Build Shareholder Value In 2009 3Microbix Uses Core Business Cashflow To Fund Late-Stage Pipeline To Build Shareholder Value In 2009 4
(Date:1/22/2015)... 2015  Analyst Report Issued by Small Cap IR. In 2011, ... planet-wide, transactions at merchants on the leading payment cards rose ... credit, debit, and prepaid cards reached 6.54 billion.  Eight million ... card usage in 2012, and credit and debit card fraud ...
(Date:1/22/2015)... Inc. , a market leader of iris-based identity authentication solutions, ... the new role of Senior Vice President of Mobile and ... platforms and wearable solutions for EyeLock,s technologies. Gerber brings more ... industry to his role at EyeLock, with expertise in human ...
(Date:12/22/2014)... Conn. , Dec. 22, 2014  NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce market, ... Apollo Robbins for the 2015 International CES debut ... Apollo Robbins will be at the NXT-ID booth January ...
Breaking Biology News(10 mins):$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 4
... light-emitting molecules have enabled researchers to visualize a ... surface using only infrared light. A team of ... University of Pennsylvania and the University of Minnesota ... surface of a polymersome, a cell-like vesicle, to ...
... drastically reduced the incidence of Kaposi's sarcoma in ... many developing countries. Now, researchers have discovered one ... traditionally associated with AIDS ?triggers severe inflammation. , ... investigator, and HHMI associate Craig McCormick, who are ...
... devices intended to optimize the cardiac function of patients ... patients might be at higher risk of dying suddenly ... Medical Center. , Besides maintaining optimal electrical stimulation to ... devices are giving cardiologists a new view of subtle ...
Cached Biology News:Self-assembled nano-sized probes allow Penn researchers to see tumors through flesh and skin 2How an AIDS-Related Cancer Unleashes Inflammation 2How an AIDS-Related Cancer Unleashes Inflammation 3Implanted Devices Detect High-Risk Heart Failure Patients 2Implanted Devices Detect High-Risk Heart Failure Patients 3
... Pathway Studio Enterprise is integrated informatics ... regulatory mechanisms and drug response modeling. ... the worlds largest knowledge base of ... with MedScan module capable of extracting ...
... The Rapid-Screen cDNA Library Panels were ... just three sets of PCRs to identify ... analysis is performed in a 96-well "Master ... from 5,000 clones. Having identified the positive ...
... Preparation Note: Prepared by a ... C.W., et al., Biotechnol. Bioeng., ... Definition: One unit will yield an ... 1.0 ml of water (1 cm ...
... White solid. PACKAGED UNDER INERT GAS. DO ... resin with applications similar to those of DTT ... , and 233155 ) but with the ... to the system. REDUCTACRYL™ Reagent can be used ...
Biology Products: